Scopolamine Patch, Extended Release
Product Images NDC 68071-3994

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 68071-3994). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3994 4)

Scopolamine 1 mg/3 days transdermal system label from NuCare Pharmaceuticals, Inc. The label states each system contains 1.5 mg Scopolamine to deliver approximately 1 mg over 3 days. Includes NDC 68071-3994-4, manufacturer details, usage warnings, and storage instructions at controlled temperature 68-77°F. The label indicates Rx only with product number R2003004.*

FDA Label Image

Image Description (Figure003)

An instructional illustration showing two hands peeling apart a protective backing from a transdermal patch. The image is likely intended to guide the user on how to properly remove the patch from its packaging before application.*

FDA Label Image

Image Description (Figure01)

An instructional diagram illustrating the components of a Scopolamine 1.5 mg extended release transdermal patch. It shows a clear, disposable plastic release liner with stipples, a metallic adhesive surface, and a tan backing membrane with an imprint indicating "Scopolamine 1 mg/3 days."*

FDA Label Image

Image Description (Figure2)

An instructional illustration showing a pouch with dashed lines indicating where to tear open. The diagram highlights the section to tear along the dashed lines for opening the pouch.*

FDA Label Image

Image Description (Figure4)

An instructional diagram showing two fingers peeling a clear, disposable plastic release liner with stipples from a metallic adhesive surface of an imprinted tan-colored transdermal patch system. The image details the parts of the extended-release transdermal patch.*

FDA Label Image

Image Description (Figure5)

Illustration showing a side profile of a person's head with an imprinted tan-colored transdermal system applied behind the ear, demonstrating typical placement of the Scopolamine patch for transdermal administration.*

FDA Label Image

Logo (Logo01)

Scopolamine 1.5 mg extended-release transdermal patch packaging from NuCare Pharmaceuticals, Inc. The rectangular carton features the Ingenus logo and a simple white and black design.*

FDA Label Image

Logo (Logo02)

Scopolamine 1.5 mg extended-release transdermal patch packaging label from NuCare Pharmaceuticals, Inc. The label features the product name prominently, with a white background and black text. The brand Ingenus appears alongside the labeler information.*

FDA Label Image

Structure (Structuralformula001)

Chemical structure of scopolamine, showing its molecular framework with a bicyclic ring system, a methylated nitrogen, and aromatic phenyl moiety with hydroxyl and carbonyl functional groups.*

FDA Label Image

System (System001)

An illustration diagram showing the layered structure of a Scopolamine transdermal patch, extended release. The layers from top to bottom are labeled as Backing Membrane, Drug in Adhesive Layer, Rate Controlling Membrane, another Drug in Adhesive Layer, and Release Liner.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.